[Musculoskeletal pain in pediatric patients. Prevalence and etiology in Primary Care]

J de Inocencio Arocena1, M A Fernández Méndez

  • 1Centro de Salud Benita de Avila, INSALUD Area IV, Madrid.

Insights

Pediatric musculoskeletal pain accounts for 6.2% of primary care visits in children aged 3 and older. Overuse syndromes and growth variants are common causes, particularly in older males.

Area of Science:

  • Pediatric primary care
  • Musculoskeletal conditions
  • Epidemiology

Context:

  • Musculoskeletal pain is a common reason for pediatric primary care visits.
  • Understanding the prevalence and causes of pediatric musculoskeletal pain is crucial for effective management.

Purpose:

  • To determine the frequency of primary care visits for pediatric musculoskeletal pain.
  • To describe the demographics of children presenting with limb or back pain.
  • To identify the etiologies of musculoskeletal pain in a general pediatric setting.

Summary:

  • A prospective study in Madrid pediatric clinics (Oct 1996-Jan 1997) found 6.2% of visits (43/692) for children aged 3+ were due to musculoskeletal pain.
  • The mean age was 9.8 years, with higher prevalence in children over 10 and males (non-significant).
  • Common complaints included knee pain, other joint arthralgias, and soft tissue pain, often linked to overuse or growth variants.

Impact:

  • Findings suggest a correlation between expanded primary pediatric care age ranges and increased musculoskeletal pain consultations.
  • Highlights the need for incorporating musculoskeletal pain management into pediatric continuing medical education.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...